Pulmonary TH2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 1, 2006, Pages 204-211

  Hartl, Dominik ^a   Griese, Matthias ^a   Kappler, Matthias ^a   Zissel, Gernot ^b   Reinhardt, Dietrich ^a   Rebhan, Christian ^a   Schendel, Dolores J ^c,d   Krauss Etschmann, Susanne ^a,d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Bronchoalveolar lavage fluid; CCR4; Cystic fibrosis; Cytokines; MDC; Pseudomonas aeruginosa; TH1 TH2; TARC

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; MONOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG INFECTION; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; THYMUS;

ADOLESCENT; ADULT; CHEMOKINES, CC; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; LUNG; MALE; PSEUDOMONAS INFECTIONS; RECEPTORS, CHEMOKINE; TH1 CELLS; TH2 CELLS;

EID: 29544436136     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.09.023     Document Type: Article

References (42)

1. J.F. Chmiel, M. Berger, and M.W. Konstan The role of inflammation in the pathophysiology of CF lung disease Clin Rev Allergy Immunol 23 2002 5 27
2. R.L. Gibson, J.L. Burns, and B.W. Ramsey Pathophysiology and management of pulmonary infections in cystic fibrosis Am J Respir Crit Care Med 168 2003 918 951
3. R.B. Fick Bronchopulmonary infectious complications of cystic-fibrosis Semin Respir Med 13 1992 205 215
4. S.C. Fitzsimmons The changing epidemiology of cystic-fibrosis J Pediatr 122 1993 1 9
5. R.B. Fick Pathogenesis of the Pseudomonas lung lesion in cystic-fibrosis Chest 96 1989 158 164
6. N. Hoiby, and C. Koch Cystic-fibrosis, 1: Pseudomonas-aeruginosa infection in cystic-fibrosis and its management Thorax 45 1990 881 884
7. R.B. Parad, C.J. Gerard, D. Zurakowski, D.P. Nichols, and G.B. Pier Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype Infect Immun 67 1999 4744 4750
8. G. Doring, and N. Hoiby Longitudinal-study of immune-response to Pseudomonas-aeruginosa antigens in cystic-fibrosis Infect Immun 42 1983 197 201
9. G. Doring Immune-response to proteases of Pseudomonas-aeruginosa by cystic-fibrosis patients Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene Series A-Medical Microbiology Infectious Diseases Virology Parasitology 253 1983 461 466
10. M.W. Konstan, K.A. Hilliard, T.M. Norvell, and M. Berger Bronchoalveolar lavage findings in cystic-fibrosis patients with stable, clinically mild lung-disease suggest ongoing infection and inflammation Am J Respir Crit Care Med 150 1994 448 454
11. D.A. Devine Antimicrobial peptides in defence of the oral and respiratory tracts Mol Immunol 40 2003 431 443
12. G.H. Warren, J. Gray, and P. Bartell The lysis of Pseudomonas-aeruginosa by lysozyme J Bacteriol 70 1955 614 619
13. E.M. Jones, A. Smart, G. Bloomberg, L. Burgess, and M.R. Millar Lactoferricin, a new antimicrobial peptide J Appl Bacteriol 77 1994 208 214
14. R.T. Ellison, and T.J. Giehl Killing of Gram-negative bacteria by lactoferrin and lysozyme J Clin Invest 88 1991 1080 1091
15. A.M. Tager, J.Y. Wu, and M.W. Vermeulen The effect of chloride concentration on human neutrophil functions: potential relevance to cystic fibrosis Am J Respir Cell Mol Biol 19 1998 643 652
16. T.S. Ilyina, Y.M. Romanova, and A.L. Gintsburg Biofilms as a mode of existence of bacteria in external environment and host body: the phenomenon, genetic control, and regulation systems of development Russ J Genet 40 2004 1189 1198
17. R.E.W. Hancock, and D.P. Speert Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment Drug Resist Updates 3 2000 247 255
18. S. Epelman, T.F. Bruno, G.G. Neely, D.E. Woods, and C.H. Mody Pseudomonas aeruginosa exoenzyme S induces transcriptional expression of proinflammatory cytokines and chemokines Infect Immun 68 2000 4811 4814
19. R.B. Fick Pseudomonas in cystic-fibrosis: sylph or sycophant Clin Chest Med 2 1981 91 102
20. R.B. Fick, and S.U. Squier Pathophysiologic mechanisms in the lung lesion of Pseudomonas-aeruginosa Chest 95 1989 S215 S216
21. N. Hoiby, L. Jacobsen, B.A. Jorgense, E. Lykkegaa, and B. Weeke Pseudomonas-aeruginosa infection in cystic-fibrosis Acta Paediatr Scand 63 1974 843 848
22. C. Moser, H.P. Hougen, Z.J. Song, J. Rygaard, A. Kharazmi, and N. Hoiby Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response APMIS 107 1999 1093 1100
23. C. Moser, P.O. Jensen, O. Kobayashi, H.P. Hougen, Z. Song, and J. Rygaard Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response Clin Exp Immunol 127 2002 206 213
24. C. Moser, S. Kjaergaard, T. Pressler, A. Kharazmi, C. Koch, and N. Hoiby The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type APMIS 108 2000 329 335
25. J. Brazova, A. Sediva, D. Pospisilova, V. Vavrova, P. Pohunek, and J. Macek Differential cytokine profile in children with cystic fibrosis Clin Immunol 115 2005 210 215
26. T.R. de Kievit, R. Gillis, S. Marx, C. Brown, and B.H. Iglewski Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns Appl Environ Microbiol 67 2001 1865 1873
27. G. Telford, D. Wheeler, P. Williams, P.T. Tomkins, P. Appleby, and H. Sewell The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-1-homoserine lactone has immunomodulatory activity Infect Immun 66 1998 36 42
28. R.S. Smith, S.G. Harris, R. Phipps, and B. Iglewski The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)homoserine lactone contributes to virulence and induces inflammation in vivo J Bacteriol 184 2002 1132 1139
29. A.J. Ritchie, A.O.W. Yam, K.M. Tanabe, S.A. Rice, and M.A. Cooley Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L- homoserine lactone Infect Immun 71 2003 4421 4431
30. F. Sallusto, A. Lanzavecchia, and C.R. Mackay Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses Immunol Today 19 1998 568 574
31. F. Sallusto, D. Lenig, C.R. Mackay, and A. Lanzavecchia Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes J Exp Med 187 1998 875 883
32. C.H. Kim, L. Rott, E.J. Kunkel, M.C. Genovese, D.P. Andrew, and L.J. Wu Rules of chemokine receptor association with T cell polarization in vivo J Clin Invest 108 2001 1331 1339
33. D. D'Ambrosio, A. Iellem, R. Bonecchi, D. Mazzeo, S. Sozzani, and A. Mantovani Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells J Immunol 161 1998 5111 5115
34. M. Griese, I. Ramakers, A. Krasselt, V. Starosta, S. van Koningsbruggen, and R. Fischer Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis Am J Respir Crit Care Med 169 2004 822 828
35. T.Z. Khan, J.S. Wagener, T. Bost, J. Martinez, F.J. Accurso, and D.W.H. Riches Early pulmonary inflammation in infants with cystic-fibrosis Am J Respir Crit Care Med 151 1995 1075 1082
36. M. Griese, J. Felber, K. Reiter, P. Strong, K. Reid, and B.H. Belohradsky Airway inflammation in children with tracheostomy Pediatr Pulmonol 37 2004 356 361
37. D. Hartl, M. Griese, T. Nicolai, G. Zissel, C. Prell, and N. Konstantopoulos Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough J Allergy Clin Immunol 115 2005 728 736
38. H. Motulsky Intuitive biostatistics 1995 Oxford University Press New York
39. R. Bonecchi, G. Bianchi, P.P. Bordignon, D. D'Ambrosio, R. Lang, and A. Borsatti Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J Exp Med 187 1998 129 134
40. R.M. Strieter, S.L. Kunkel, M.P. Keane, and T.J. Standiford Chemokines in lung injury: Thomas A. Neff lecture Chest 116 1999 103S 110S
41. J.A. Belperio, M.P. Keane, M.D. Burdick, J.P. Lynch, Y.Y. Xue, and K.W. Li Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome J Immunol 169 2002 1037 1049
42. T.L. Bonfield, J.R. Panuska, M.W. Konstan, K.A. Hilliard, J.B. Hilliard, and H. Ghnaim Inflammatory cytokines in cystic-fibrosis lungs Am J Respir Crit Care Med 152 1995 2111 2118